tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Ownership - Who Owns Immunovant?

731 Followers

Immunovant (IMVT) Ownership Overview

58.07%14.10%8.19%19.64%
58.07% Insiders
8.19% Other Institutional Investors
19.64% Public Companies and
Individual Investors
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail and individual investors. Approximately 22.29% of the company’s stock is owned by Institutional Investors, 58.07% is owned by Insiders and 19.64% is owned by Public Companies and Individual Investors.
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail and individual investors. Approximately 22.29% of the company’s stock is owned by Institutional Investors, 58.07% is owned by Insiders and 19.64% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 19, 2024
xxxxxxxxxxxxx
$85132
Jul 19, 2024
xxxxxxxxxxxxx
$90386
Jul 19, 2024
xxxxxxxxxxxxx
$92733
Jul 19, 2024
Peter Salzmann
Ceo,director
xxxxxxxxxxxxx
$257888

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$94086
Mar 31, 2024
xxxxxxxxxxxxx
$6160095
Mar 31, 2024
xxxxxxxxxxxxx
$41663874
Mar 31, 2024
xxxxxxxxxxxxx
$58454347

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,260,046Institution4.28%175,093,487
5,741,815Institution3.93%160,598,566
3,770,260Institution2.58%105,454,172
2,963,212Institution2.03%82,881,040
2,872,612Institution1.97%80,346,958
1,809,172Institution1.24%50,602,541
1,524,048Institution1.04%42,627,623
1,428,000Institution0.98%39,941,160
1,289,504Institution0.88%36,067,427
822,543Institution0.56%23,006,528

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,741,815Institution3.93%160,598,566
3,770,260Institution2.58%105,454,172
1,428,000Institution0.98%39,941,160
822,543Institution0.56%23,006,528
802,858Institution0.55%22,455,938
780,367Institution0.53%21,826,865
619,540Institution0.42%17,328,534
619,154Institution0.42%17,317,737
615,000Institution0.42%17,201,550
604,445Institution0.41%16,906,327

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,113,168Institution1.45%55,787,635
1,652,106Institution1.13%43,615,598
1,548,567Institution1.06%43,313,419
1,446,081Institution0.99%41,083,161
1,111,755Institution0.76%29,350,332
872,932Institution0.60%23,045,405
520,706Institution0.36%14,564,147
453,121Institution0.31%12,673,794
267,070Institution0.18%7,587,459
216,096Institution0.15%5,704,934

FAQ

Who Owns Immunovant (IMVT)?
According to the latest TipRanks data, approximately 8.19% of the company's stock is held by institutional investors, 58.07% is held by insiders, and 19.64% is held by retail investors.
    What percentage of Immunovant (IMVT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.19% of Immunovant (IMVT) stock is held by institutional investors.
      What percentage of Immunovant (IMVT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 19.64% of Immunovant (IMVT) stock is held by retail investors.
        Who owns the most shares of Immunovant (IMVT)?
        Vanguard owns the most shares of Immunovant (IMVT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis